Lipert Maya P, Roy Lilly, Childs Scott L, Rodríguez-Hornedo Naír
Department of Pharmaceutical Sciences, University of Michigan, Ann Arbor, Michigan 48109-1065.
Renovo Research, Atlanta, Georgia 30316.
J Pharm Sci. 2015 Dec;104(12):4153-4163. doi: 10.1002/jps.24640. Epub 2015 Sep 21.
This work examines cocrystal solubility in biorelevant media (FeSSIF, fed-state simulated intestinal fluid), and develops a theoretical framework that allows for the simple and quantitative prediction of cocrystal solubilization from drug solubilization. The solubilities of four hydrophobic drugs and seven cocrystals containing these drugs were measured in FeSSIF and in acetate buffer at pH 5.00. In all cases, the cocrystal solubility (Scocrystal ) was higher than the drug solubility (Sdrug ) in both buffer and FeSSIF; however, the solubilization ratio of drug, SRdrug = (SFeSSIF /Sbuffer )drug , was not the same as the solubilization ratio of cocrystal, SRcocrystal = (SFeSSIF /Sbuffer )cocrystal , meaning drug and cocrystal were not solubilized to the same extent in FeSSIF. This highlights the potential risk of anticipating cocrystal behavior in biorelevant media based on solubility studies in water. Predictions of SRcocrystal from simple equations based only on SRdrug were in excellent agreement with measured values. For 1:1 cocrystals, the cocrystal solubilization ratio (SR) can be obtained from the square root of the drug SR. For 2:1 cocrystals, SRcocrystal is found from (SRdrug )(2/3) . The findings in FeSSIF can be generalized to describe cocrystal behavior in other systems involving preferential solubilization of a drug such as surfactants, lipids, and other drug solubilizing media.
本研究考察了共晶在生物相关介质(FeSSIF,进食状态模拟肠液)中的溶解度,并建立了一个理论框架,可根据药物溶解度对共晶溶解进行简单定量预测。测定了四种疏水性药物以及包含这些药物的七种共晶在FeSSIF和pH 5.00的醋酸盐缓冲液中的溶解度。在所有情况下,共晶溶解度(Scocrystal)在缓冲液和FeSSIF中均高于药物溶解度(Sdrug);然而,药物的溶解比,SRdrug = (SFeSSIF /Sbuffer)drug,与共晶的溶解比,SRcocrystal = (SFeSSIF /Sbuffer)cocrystal,并不相同,这意味着药物和共晶在FeSSIF中的溶解程度不同。这突出了基于水中溶解度研究来预测共晶在生物相关介质中行为的潜在风险。仅基于SRdrug的简单方程对SRcocrystal的预测与测量值高度吻合。对于1:1共晶,共晶溶解比(SR)可从药物SR的平方根得出。对于2:1共晶,SRcocrystal可由(SRdrug)(2/3)得出。在FeSSIF中的研究结果可推广用于描述其他涉及药物优先溶解的体系(如表面活性剂、脂质和其他药物增溶介质)中共晶的行为。